Angiotensin-converting enzyme, renin-angiotensin system and human performance

Medicine and Sport Science

Volumn 54, Issue , 2009, Pages 72-87

  Woods, David ^a,b,c  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b Royal Army Medical Corps   (United Kingdom)

^c ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ALTITUDE; ARTICLE; ATHLETIC PERFORMANCE; ENDURANCE; GENETIC POLYMORPHISM; GENETICS; HUMAN; OXYGEN CONSUMPTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ALTITUDE; ATHLETIC PERFORMANCE; HUMANS; OXYGEN CONSUMPTION; PEPTIDYL-DIPEPTIDASE A; PHYSICAL ENDURANCE; POLYMORPHISM, GENETIC; RENIN-ANGIOTENSIN SYSTEM;

EID: 72049096880     PISSN: 02545020     EISSN: 16622812     Source Type: Book Series    
DOI: 10.1159/000235697     Document Type: Article

References (88)

1. Rigat B, Hubert C, Alhencgelas F, Cambien F, Corvol P, Soubrier F: An insertion deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-1346.
2. Miller GJ, Bauer KA, Barzegar S, Cooper JA, Rosenberg RD: Increased activation of the haemostatic system in men at high risk of fatal coronary heart disease. Thrombosis Haemost 1996;75:767-771.
3. Barley J, Blackwood A, Carter ND, Crews DE, Cruickdshank JK, Jeffery S, Ogunlesi AO, Sagnella GA: Angiotensin converting enzyme insertion/deletion polymorphism: association with ethnic origin. J Hypertens 1994;12:955-957.
4. Foy C, McCormack LJ, Knowler WC, Barrett JH, Catto A, Grant PJ: The angiotensin-1 converting enzyme (ACE) gene I/D polymorphism and ACE levels in Pima Indians. J Med Genet 1996;33:336-337.
5. Barley J, Blackwood A, Miller M, Markandu ND, Carter ND, Jeffery S, Cappuccio FP, MacGregor GA, Sagnella GA: Angiotensin converting enzyme gene I/D polymorphism, blood pressure and the reninangiotensin system in Caucasian and Afro-Caribbean peoples. J Hum Hypertens 1996;10:31-35.
6. Sagnella GA, Rothwell MJ, Onipinla AK, et al: A population study of ethnic variations in the angiotensin- converting enzyme I/D polymorphism: relationships with gender, hypertension and impaired glucose metabolism. J Hypertens 1999;17:657-664.
7. Cambien F, Costerousse O, Tiret L, Poirier O, Lecerf L, Gonzales MF, Evans A, Arveiler D, Cambou JP, Luc G, Rakotovao R, Ducimetiere P, Soubrier F, Alhenc-Gelas F: Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation 1994;90:669-676. (Pubitemid 24242731)
8. Busjahn A, Knoblauch H, Knoblauch M, Bohlender J, Menz M, Faulhaber HD, Becker A, Schuster H, Luft FC: Angiotensin-converting enzyme and angiotensinogen gene polymorphisms, plasma levels, cardiac dimensions: a twin study. Hypertension 1997;29:165-170.
9. Danser AH, Derkx FH, Hense HW, Jeunemaitre X, Riegger GA, Schunkert H: Angiotensinogen (M235T) and angiotensin-converting enzyme (I/D) polymorphisms in association with plasma renin and prorenin levels. J Hypertens 1998;16:1879-1883.
10. Agerholm-Larsen B, Tybjserg-Hansen A, Schnohn P, Nordestgaard BG: ACE gene polymorphism explains 30-40% of variability in serum ACE activity in both women and men in the population at large: the Copenhagen City Heart study. Atherosclerosis 1999;147:425-427.
11. Kohno M, Yokokawa K, Minami, M, Kano H, Yasunari K, Hanehira T, Yoshikawa J: Association between angiotensin-converting enzyme gene polymorphisms and regression of left ventricular hypertrophy in patients treated with angio tensin-converting enzyme inhibitors. Am J Med 1999;106:544-549.
12. Rossi GP, Narkiewicz K, Cesari M, Winnicki M, Bigda J, Chrostowska M, Szczech R, Pawlowski R, Pessina AC: Genetic determinants of plasma ACE and renin activity in young normotensive twins. J Hypertens 1999;17:647-655.
13. Martinez EPA, Escribano J, Sanchis C, Carrion L, Artigao M, Divison JA, Masso J, Vidal A, Fernandez JA: Angiotensin-converting enzyme (ACE) gene polymorphisms, serum ACE activity and blood pressure in a Spanish-Mediterranean population. J Hum Hypertens 2000;14:131-135.
14. Scott RA, Moran C, Wilson RH, Onywera V, Boit MK, Goodwin WH, Gohlke P, Payne J, Montgomery H, Pitsiladis YP: No association between Angiotensin Converting Enzyme (ACE) gene variation and endurance athlete status in Kenyans. Comp Biochem Physiol A Mol Integr Physiol 2005;141:169-175.
15. Bloem LJ, Manatunga AK, Pratt JH: Racial difference in the relationship of an angiotensin I- converting enzyme gene polymorphism to serum angiotensin I- converting enzyme activity. Hypertension 1996;27:62-66.
16. Payne JR, Dhamrait SS, Gohlke P, Cooper J, Scott RA, Pitsiladis YP, Humphries SE, Rayner B, Montgomery HE: The impact of ACE genotype on serum ACE activity in a black South African male population. Ann Hum Genet 2007;71:1-7.
17. Brunner HR, Laragh JH, Baer L: Essential hypertension: renin and aldosterone, heart attack and stroke. N Engl J Med 1972;286:441-449.
18. Kotchen TA, Guthrie GP Jr, Cottrill CM, McKean HE, Kotchen JM: Low renin-aldosterone in 'prehypertensive' young adults. J Clin Endocrinol Metab 1982;54:808-814.
19. Pratt JH, Jones JJ, Miller JZ, Wagner MA, Fineberg NS: Racial differences in aldosterone excretion and plasma aldosterone concentrations in children. N Engl J Med 1989;321:1152-1157.
20. Myerson S, Hemingway H, Budget R, et al: Human angiotensin I-converting enzyme gene and endurance performance. J Appl Physiol 1999;87:1313-1316.
21. Gayagay G, Yu B, Hambly B, Boston T, Hahn A, Celermajer DS, Trent RJ: Elite endurance athletes and the ACE I allele - the role of genes in athletic performance. Hum Genet 1998;103:48-50.
22. Karjalainen J, Kujala UM, Stolt A, Mantysaari M, Viitasalo M, Kainulainen K, Kontula K: Angiotensinogen gene M235T polymorphism predicts left ventricular hypertrophy in endurance athletes. J Am Coll Cardiol 1999;34:494-499.
23. Taylor RR, Mamotte CDS, Fallon K, Bockxmeer FM: Elite athletes and the gene for angiotensin-converting enzyme. J Appl Physiol 1999;87:1035-1037.
24. Rankinen T, Wolfarth B, Simoneau J, et al: No association between the angiotensin-converting enzyme ID polymorphism and elite endurance athlete status. J Appl Physiol 2000;88:1571-1575.
25. Nazarov IB, Woods DR, Montgomery HE, et al: The angiotensin converting enzyme I/D polymorphism in Russian athletes. Eur J Hum Genet 2001;9:797-801.
26. Scanavini D, Bernardi F, Castoldi E, Conconi F, Mazzoni G: Increased frequency of the homozygous II ACE genotype in Italian Olympic endurance athletes. Eur J Hum Gen 2002;10:576-577.
27. Oh SD: The distribution of I/D polymorphism in the ACE gene among Korean male elite athletes. J Sports Med Phys Fitness 2007;47:250-254.
28. Alvarez R, Terrados N, Ortolano R, Iglesias-Cubero G, Reguero JR, Batalla A, Cortina A, Fernandez- Garcia B, Rodriguez C, Braga S, Alvarez V, Coto E: Genetic variation in the renin-angiotensin system and athletic performance. Eur J Appl Physiol 2000; 82:117-120.
29. Juffer P, Furrer R, Gonzalez-Freire M, Santiago C, Verde Z, Serratosa L, Morate FJ, Rubio JC, Martin MA, Ruiz JR, Arenas J, Gomez-Gallego F, Lucia A: Genotype distributions in top-level soccer players: a role for ACE? Int J Sports Med 2009, Epub ahead of print.
30. Lucia A, Gomez-Gallego F, Chicharro JL, Hoyos J, Celaya K, Cordova A, Villa G, Alonso JM, Barriopedro M, Perez M, Earnest CP: Is there an association between ACE and CKMM polymorphisms and cycling performance status during 3-week races? Int J Sports Med 2005;26:442-447.
31. Muniesa CA, Gonzalez-Freire M, Santiago C, Lao JI, Buxens A, Rubio JC, Martin MA, Arenas J, Gomez-Gallego F, Lucia A: World-class performance in lightweight rowing: is it genetically influenced? A comparison with cyclists, runners and non-athletes. Br J Sports Med 2008, Epub ahead of print.
32. Collins M, Xenophontos SL, Cariolou MA, Mokone GG, Hudson DE, Anastasiades L, Noakes TD: The ACE gene and endurance performance during the South African Ironman Triathlons. Med Sci Sports Exerc 2004;36:1314-1320.
33. Hruskovicova H, Dzurenkova D, Selingerova M, Bohus B, Timkanicova B, Kovacs L: The angiotensin converting enzyme I/D polymorphism in long distance runners. J Sports Med Phys Fitness 2006;46: 509-513.
34. Hawley JA, Williams MM: Relationship between upper body anaerobic power and freestyle swimming performance. Int J Sports Med 1991;12:1-5.
35. Hawley JA, Williams MM, Vickovic MM, Handcock PJ: Muscle power predicts freestyle swimming performance. Br J Sports Med 1992;26:151-155.
36. Woods DR, Hickmann M, Jamshidi Y, et al: Elite swimmers and the D allele of the ACE I/D polymorphism. Hum Genet 2001;108:230-232.
37. Tsianos G, Sanders J, Dhamrait S, Humphries S, Grant S, Montgomery H: The ACE gene insertion/ deletion polymorphism and elite endurance swimming. Eur J Appl Physiol 2004;92:360-362.
38. Montgomery HE, Marshall RM, Hemingway H, et al: Human gene for physical performance. Nature 1998;393:221-222.
39. Cam S, Colakoglu M, Colakoglu S, Sekuri C, Berdeli A: ACE I/D gene polymorphism and aerobic endurance development in response to training in a nonelite female cohort. J Sports Med Phys Fitness 2007; 47:234-238.
40. Sonna LA, Sharp MA, Knapik JJ, et al: Angiotensinconverting enzyme genotype and physical performance during US Army basic training. J Appl Physiol 2001;91:1355-1363.
41. Cerit M, Colakoglu M, Erdogan M, Berdeli A, Cam FS: Relationship between ACE genotype and short duration aerobic performance development. Eur J Appl Physiol 2006;98:461-465.
42. Folland J, Leach B, Little T, Hawker K, Myerson S, Montgomery H, Jones D: Angiotensin-converting enzyme genotype affects the response of human skeletal muscle to functional overload. Exp Physiol 2000;85:575-579.
43. Colakoglu M, Cam FS, Kayitken B, Cetinoz F, Colakoglu S, Turkmen M, Sayin M: ACE genotype may have an effect on single versus multiple set preferences in strength training. Eur J Appl Physiol 2005;95:20-26.
44. Giaccaglia V, Nicklas B, Kritchevsky S, Mychalecky J, Messier S, Bleecker E, Pahor M: Interaction between angiotensin converting enzyme insertion/ deletion genotype and exercise training on knee extensor strength in older individuals. Int J Sports Med 2008;29:40-44.
45. Charbonneau DE, Hanson ED, Ludlow AT, Delmonico MJ, Hurley BF, Roth SM: ACE genotype and the muscle hypertrophic and strength responses to strength training. Med Sci Sports Exerc 2008; 40:677-683.
46. Pescatello LS, Kostek MA, Gordish-Dressman H, Thompson PD, Seip RL, Price TB, Angelopoulos TJ, Clarkson PM, Gordon PM, Moyna NM, Visich PS, Zoeller RF, Devaney JM, Hoffman EP: ACE ID genotype and the muscle strength and size response to unilateral resistance training. Med Sci Sports Exerc 2006;38:1074-1081.
47. Thomis MA, Huygens W, Heuninckx S, Chagnon M, Maes HH, Claessens AL, Vlietinck R, Bouchard C, Beunen GP: Exploration of myostatin polymorphisms and the angiotensin-converting enzyme insertion/deletion genotype in responses of human muscle to strength training. Eur J Appl Physiol 2004;92:267-274.
48. Thompson J, Raitt J, Hutchings L, Drenos F, Bjargo E, Loset A, Grocott M, Montgomery H, Caudwell Xtreme Everest Research Group: Angiotensinconverting enzyme genotype and successful ascent to extreme high altitude. High Alt Med Biol 2007; 8:278-285.
49. Tsianos G, Eleftheriou KI, Hawe E, Woolrich L, Watt M, Watt I, Peacock A, Montgomery H, Grant S: Performance at altitude and angiotensin I-converting enzyme genotype. Eur J Appl Physiol 2005; 93:630-633.
50. Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F: Angiotensin-I converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J 1993; 290:33-40.
51. Danser AHJ, Schalekamp MADH, Bax WA, van den Brink AM, Saxena PR, Reigger GAJ, Schunkert H: Angiotensin converting enzyme in the human heart: effect of the deletion/insertion polymorphism. Circulation 1995;92:1387-1388.
52. Davis GK, Millner RW, Roberts DH: Angiotensin converting enzyme (ACE) gene expression in the human left ventricle: effect of ACE gene insertion/ deletion polymorphism and left ventricular function. Eur J Heart Fail 2000;2:253-256.
53. Mizuiri S, Hemmi H, Kumanomidou H, et al: Angiotensin-converting enzyme (ACE) I/D genotype and renal ACE gene expression. Kidney Int 2001;60:1124-1130.
54. Brown NJ, Blais C, Gandhi SK, Adam A: ACE insertion/ deletion genotype affects bradykinin metabolism. J Cardiovasc Pharmacol 1998;32:373-377.
55. Ueda S, Elliott HL, Morton JJ, Connell JMC: Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype (DD) for angiotensin-converting enzyme. Hypertension 1995;25:1266-1269.
56. Buikem H, Pinto YM, Rooks G, Grandjean JG, Schunkert H, van Gilst WH: The deletion polymorphism of the angiotensin-converting enzyme gene is related to phenotypic differences in human arteries. Eur Heart J 1996;17:787-794.
57. van Dijk MA, Kroon I, Kamper AM, Boomsma F, Danser AH, Chang PC: The angiotensin-converting enzyme gene polymorphism and responses to angiotensins and bradykinin in the human forearm. J Cardiovasc Pharmacol 2000;35:484-490.
58. Gordon SE, Davis BS, Carlson CJ, Booth FW: ANG II is required for optimal overload-induced skeletal muscle hypertrophy. Am J Physiol Endocrinol Metab 2001;280:E150-E159.
59. McBride TA: AT1 receptors are necessary for eccentric training-induced hypertrophy and strength gains in rat skeletal muscle. Exp Physiol 2006;91: 413-421.
60. Rattigan S, Dora KA, Tong AC, Clark MG: Perfused skeletal muscle contraction and metabolism improved by angiotensin II-mediated vasoconstriction. Am J Physiol 1996;271:E96-E103.
61. Brink M, Price SR, Chrast J, Bailey JL, Anwar A, Mitch WE, Delafontaine P: Angiotensin II induces skeletal muscle wasting through enhanced protein degradation and down-regulates autocrine insulinlike growth factor I. Endocrinology 2001;142:1489-1496.
62. Jones A, Woods DR: Skeletal muscle RAS and exercise performance. Int J Biochem Cell Biol 2003; 35:855-866.
63. Rett K, Wicklmayr M, Dietze GJ: Metabolic effects of kinins: historical and recent developments. J Cardiovasc Pharmacol 1990;15(suppl 6):S57-S59.
64. Shiuchi T, Nakagami H, Iwai M, Takeda Y, Cui T, Chen R, Minokoshi Y, Horiuchi M: Involvement of bradykinin and nitric oxide in leptin-mediated glucose uptake in skeletal muscle. Endocrinology 2001; 142:608-612.
65. Langberg H, Bjorn C, Boushel R, Hellsten Y, Kjaer M: Exercise-induced increase in interstitial bradykinin and adenosine concentrations in skeletal muscle and peritendinous tissue in humans. J Physiol 2002; 542:977-983.
66. Boix F, Roe C, Rosenborg L, Knardahl S: Kinin peptides in human trapezius muscle during sustained isometric contraction and their relation to pain. J Appl Physiol 2005;98:534-540.
67. Dietze GJ, Wicklmayr M, Rett K, Jacob S, Henriksen EJ: Potential role of bradykinin in forearm muscle metabolism in humans. Diabetes 1996;45:S110-S114.
68. Tanriverdi H, Evrengul H, Tanriverdi S, Turgut S, Akdag B, Kaftan HA, Semiz E: Improved endothelium dependent vasodilation in endurance athletes and its relation with ACE I/D polymorphism. Circ J 2005;69:1105-1110.
69. Butler R, Morris AD, Burchell B, Struthers AD: DD Angiotensin-converting enzyme gene polymorphism is associated with endothelial dysfunction in normal humans. Hypertension 1999;33:1164-1168.
70. Coyle EF, Sidossis LS, Horowitz JF, Beltz JD: Cycling efficiency is related to the percentage of type I muscle fibers. Med Sci Sports Exerc 1992;24:782-788.
71. Shimojo N, Chao J, Chao L, Margolius HS, Mayfield RK: Identification and characterization of a tissue kallikrein in rat skeletal muscles. Biochem J 1987; 243:773-778.
72. Ferrario CM, Iyer SN: Angiotensin-(1-7): a bioactive fragment of the renin-angiotensin system. Reg Pep 1998;78:13-18.
73. Rankinen T, Perusse L, Gagnon J, et al: Angiotensinconverting enzyme ID polymorphism and fitness phenotype in the HERITAGE Family Study. J Appl Physiol 2000;88:1029-1035.
74. Woods DR, World M, Rayson MP, Williams AG, Jubb M, Jamshidi Y, Hayward M, Mary DASG, Humphries SE, Montgomery HE: Endurance enhancement related to the human angiotensin I-converting enzyme I-D polymorphism is not due to differences in the cardiorespiratory response to training. Eur J Appl Physiol 2002;86:240-244.
75. Hagberg J, Ferrell M, McCole RE, Wilund SD, Moore GE: VO2max is associated with ACE genotype in postmenopausal women. J Appl Physiol 1998; 85:1842-1846.
76. Williams AG, Rayson MP, Jubb M, World M, Woods DR, Hayward M, Martin J, Humphries SE, Montgomery HE: The ACE gene and muscle performance. Nature 2000;403:614.
77. Kanazawa H, Otsuka T, Hirata K, Yoshikawa J: Association between the angiotensin-converting enzyme gene polymorphisms and tissue oxygenation during exercise in patients with COPD. Chest 2002;21:697-701.
78. Zhang X, Wang C, Dai H, Lin Y, Zhang J: Association between angiotensin-converting enzyme gene polymorphisms and exercise performance in patients with COPD. Respirology 2008;13:683-688.
79. Day SH, Gohlke P, Dhamrait SS, Williams AG: No correlation between circulating ACE activity and VO2max or mechanical efficiency in women. Eur J Appl Physiol 2007;99:11-18.
80. Zhang B, Tanaka H, Shono N, Miura S, Kiyonaga A, Shindo M, Saku K: The I allele of the angiotensinconverting enzyme gene is associated with an increased percentage of slow-twitch type I fibers in human skeletal muscle. Clin Genet 2003;63:139-144.
81. Dehnert C, Weymann J, Montgomery HE, Woods D, Maggiorini M, Scherrer U, Gibbs JS, Bartsch P: No association between high-altitude tolerance and the ACE I/D gene polymorphism. Med Sci Sports Exerc 2002;34:1928-1933.
82. Koehle MS, Wang P, Guenette JA, Rupert JL: No association between variants in the ACE and angiotensin II receptor 1 genes and acute mountain sickness in Nepalese pilgrims to the Janai Purnima Festival at 4380 m. High Alt Med Biol 2006;7:281-289.
83. Hotta J, Hanaoka M, Droma Y, Katsuyama Y, Ota M, Kobayashi T: Polymorphisms of renin-angiotensin system genes with high-altitude pulmonary edema in Japanese subjects. Chest 2004;126:825-830.
84. Woods DR, Pollard AJ, Collier DJ, Jamshidi Y, Vassiliou V, Hawe E, Humphries SE, Montgomery HE: Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene and arterial oxygen saturation at high altitude. Am J Respir Crit Care Med 2002;166:362-366.
85. Bigham AW, Kiyamu M, Leon-Velarde F, Parra EJ, Rivera-Ch M, Shriver MD, Brutsaert TD: Angiotensin- converting enzyme genotype and arterial oxygen saturation at high altitude in Peruvian Quechua. High Alt Med Biol 2008;9:167-178.
86. Allen AM, Zhuo J, Mendelsohn FA: Localization and function of angiotensin AT1 receptors. Am J Hypertens 2000;13:31S-38S.
87. Patel S, Woods DR, Macleod NJ, Brown A, Patel KR, Montgomery HE, Peacock AJ: Angiotensin-converting enzyme genotype and the ventilatory response to exertional hypoxia. Eur Respir J 2003; 22:755-760.
88. Wang P, Fedoruk MN, Rupert JL: Keeping pace with ACE: are ACE inhibitors and angiotensin II type 1 receptor antagonists potential doping agents? Sports Med 2008;38:1065-1079.